# Autologous Adipose Derived Mesenchymal Stem Cells for Spinal Cord Injury Patients

> **NCT04520373** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Mayo Clinic** · enrollment: 40 (estimated)

## Conditions studied

- Spinal Cord Injuries
- Paralysis

## Interventions

- **OTHER:** Best Medical Management: Occupational and Physical Therapy
- **BIOLOGICAL:** Autologous, Adipose Derived Mesenchymal Stem Cells

## Key facts

- **NCT ID:** NCT04520373
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-06-25
- **Primary completion:** 2026-07
- **Final completion:** 2026-07
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04520373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04520373, "Autologous Adipose Derived Mesenchymal Stem Cells for Spinal Cord Injury Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04520373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*